NATIONAL IMMUNIZATION CONFERENCE: U.S. IMMUNIZATION IN A TIME OF CHANGE [NIC:USITC] CM2371 AGENDA

Transcription

1 NATIONAL IMMUNIZATION CONFERENCE: U.S. IMMUNIZATION IN A TIME OF CHANGE [NIC:USITC] CM2371 AGENDA September 29, am 5pm Registration 8am 5pm Info Desk September 30, am 5pm Registration 8am 5pm Info Desk 8:30am 9:30am 9:30am 9:45am Opening Plenary (PL1) Awards Presentation (no CE) 8:30am 9:45am Breakout session D (concurrent sessions: D1, D2, D3) 9:45am 10:00am 15-minute break (no CE) 9:45am 10:00am 15-minute break (no CE) 10:00am 11:15am Breakout session A (concurrent sessions: A1, A2, A3) 10:00am 11:15am Plenary Session (PL3) 11:15am 11:30am 15-minute break (no CE) 11:15am 11:30am 15-minute break (no CE) 11:30am 12:45pm Breakout session B (concurrent sessions: B1, B2, B3) 11:30am 12:45pm Breakout session E (concurrent sessions: E1, E2, E3) 12:45pm 1:15pm 30-minute break (no CE) 12:45pm 1:15pm 30-minute break (no CE) 1:15pm 2:30pm Immunization Q&A #1 (QA1; during lunch break) 1:15pm 2:30pm Measles Late-Breaker (no CE) -and- Immunization Q&A #2 (QA2; during lunch break) 2:30pm 2:45pm 15-minute break (no CE) 2:30pm 2:45pm 15-minute break (no CE) 2:45pm 4:00pm Plenary Session (PL2) 2:45pm 4:00pm Breakout session F (concurrent sessions: F1, F2, F3) 4:00pm 4:15pm 15-minute break (no CE) 4:00pm 4:15pm 15-minute break (no CE) 4:15pm 5:30pm Breakout session C (concurrent sessions: C1, C2, C3) 4:15pm 5:30pm Closing Plenary (PL4) 5:30pm Adjourn 5:30pm Adjourn 5:45pm? Hilleman Lecture (no CE) 1

2 FACULTY Name Credentials (Degrees, Position Title, Organization Name) Aguiluz, Claudia BS. Public Health Advisor, National Centers for Immunization and Respiratory Albert, Alison MPH. Health Communications Specialist, Centers for Disease Control, San Diego Quarantine Station Amato, Melanie BAC (Bachelors in Communications). Public Information Officer, Ohio Department of Public Health Bahta, Lynn RN, PHN. Immunization Program Clinical Consultant, Minnesota Department of Health Bialek, Stephanie MD, MPH. Medical Epidemiologist, Team Lead, National Centers for Immunization and Respiratory Breakwell, Lucy BSc, PhD, MSc. Epidemic Intelligence Service Officer, National Centers for Immunization and Respiratory Bresee, Joseph MD. Chief, Epidemiology and Prevention Branch, National Center for Immunization and Respiratory Carson, Janice M. MD, MSA. Deputy Director, Performance, Quality and Outcomes, Georgia Department of Community Health Craig, Allen MD. Team Lead for Africa Team, Polio Response, Center for Global Health, Centers for Disease Daniel, James MPH. Public Health Coordinator, Office of the National Coordinator for Health Information Technology, U. S. Department of Health and Human Services Donoghue, Karen RN, BS. Adult Immunization Coordinator, Department of Health and Human Services, Division of Public Health Services, New Hampshire Immunization Program Ernst, Karen Voices for Vaccines and Moms Who Vax Fedorowicz, Annie MPH. Adult Immunization Outreach Specialist, Minnesota Department of Health (Anna) Fisher, Allison Kennedy MPH. Health Communication Specialist, National Center for Immunization and Respiratory Gershman, Mark D. MD. Medical Officer, Division of Global Migration and Quarantine, Centers for Disease Givner, Laurence MD. Professor and Interim Chair, Department of Pediatrics, Wake Forest School of Medicine Goodson, James L. Epidemiologist and Measles Subject-Matter Expert, Global Immunization Division, Centers for Disease Graitcer, Samuel MD. Medical Officer, Pandemic Influenza Vaccine Program Coordinator, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Greby, Stacie M. DVM, MPH. Epidemiologist, National Center for Immunization and Respiratory Groom, Amy MPH. Public Health Advisor, National Center for Immunization and Respiratory Hall, Laura Lee PhD. Director, Center for Quality, American College of Physicians Hariri, Susan PhD, MPH. Senior Epidemiologist, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease 2

3 Name Credentials (Degrees, Position Title, Organization Name) Hawks, Debra MPH. Senior Director, Practice Activities, Obstetrics and Strategic Initiatives, American College of Obstetricians and Gynecologists Jackson, Rebel RN, BSN, MPA. Vaccines for Children Program Coordinator, National Center for Immunization and Respiratory Jorstad, Connie M. MPP, MA. Director, Emerging Infections, Association of State and Territorial Health Officials Karron, Ruth A. MD. Professor, International Health; Director, Center for Immunization Research; Director, Johns Hopkins Vaccine Initiative, Bloomberg School of Public Health, Johns Hopkins University Kim, Lindsay MD, MPH. Medical Epidemiologist, National Center for Immunization and Respiratory Kroger, Andrew MD, MPH. Medical Officer, National Center for Immunization and Respiratory Kuramoto, Sydney BS, MPH. Minnesota Immunization and Information Connection (MIIC) Epidemiologist, Minnesota Department of Health Liang, Jennifer DVM, MPVM. Epidemiologist, National Center for Immunization and Respiratory Lindley, Megan MPH. Deputy Associate Director for Science, Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Markowitz, Lauri MD. Team Lead, Epidemiology Research, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Martinez-Rubin, Norma MPH, MBA. Vaccine Storage and Handling Project Coordinator, California Department of Public Health McNamara, Lucy PhD, MS. Epidemic Intelligence Service Officer, National Center for Immunization and Respiratory Morita, Julie MD. Deputy Commissioner, Chicago Department of Public Health Omer, Saad B. MBBS, MPH, PhD. Associate Professor, Emory University, Rollins School of Public Health, Hubert Department of Global Health Parker Fiebelkorn, Amy MSM, MPH. Epidemiologist, National Center for Immunization and Respiratory Payne, Daniel PhD, MSPH. Epidemiologist, National Center for Immunization and Respiratory Perri, Bianca R. MPH. Field Operations Coordinator, Vaccines for Children (VFC) Program, New York City Department of Health and Mental Hygiene Pilishvili, Tamara MPH. Epidemiologist, National Center for Immunization and Respiratory Diseases, Centers for Disease Reader-Jolley, Danielle BS, MHS. Independent Consultant, Project Manager Reel, Amy BA Journalism. Public Affairs Director, Indiana State Department of Health Roark, Jill B. MPH. Health Communications Specialist, National Center for Immunization and Respiratory Roberts, Michele MPH, MCHES. Office Director, Washington State Department of Health, Office of Immunization and CHILD Profile Rothholz, Mitchel C. RPh, MBA. Chief Strategy Officer, American Pharmacists Association Roush, Sandra W. MT, MPH. Surveillance Officer, National Center for Immunization and Respiratory 3

4 Name Sanchez, Stephanie Saraiya, Mona Schoof, Belinda K. Schreiber, Benjamin Schuchat, Anne Skoff, Tami Stevens-Masten, Sherell Stevenson, John Stewart, Alexandra M. Stokley, Shannon Strikas, Raymond Swanson, Robert Swanson, Wendy Sue Talbot, H. Keipp Talebian, Pejman Talkington, Kathy Urquhart, Gary A. Volk, Maria E. Washburn, Tricia Weaver, Donna Williams, Christina P. Winkler, Reva Wolicki, JoEllen Zucker, Jane R. Credentials (Degrees, Position Title, Organization Name) Associates. AFIX Coordinator, Michigan Department of Community Health Division of Immunization MD, MPH. Assistant Director, Office of International Cancer Control, Centers for Disease MHA, CPHQ. Director, Health of the Public and Science Division, American Academy of Family Physicians BSc, MSc, MBA. Senior Immunization Advisor, UNICEF MD. Director, National Center for Immunization and Respiratory Diseases, Centers for Disease MS. Epidemiologist, National Center for Immunization and Respiratory Diseases, Centers for Disease MPA. Vaccines for Children Coordinator, South Carolina Department of Health and Environmental Control MA. Mathematical Statistician, National Center for Immunization and Respiratory JD. Associate Professor, Milken Institute, School of Public Health, Department of Health Policy at The George Washington University MPH. Associate Director for Science, National Center for Immunization and Respiratory MD, MPH. Medical Officer, National Center for Immunization and Respiratory MPH. Immunization Program Manager, Michigan Department of Community Health MD, MBE. Pediatrician; Executive Director of Digital Health, Seattle Children s Hospital MD, MPH. Assistant Professor, Vanderbilt University Medical Center MA, MPH. Director, Immunization Program, Massachusetts Department of Public Health MPAff. Senior Director, Infectious Disease and Immunization Policy, Association of State and Territorial Health Officials BSc, MPH. Branch Chief, Immunization Information Systems Support Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention BS, MPA. Public Health Advisor / Chief, Field Services and Program Coordination, Centers for Disease assigned to California Department of Public Health, Immunization Branch BS. Chief, Office of Immunization, Rhode Island Department of Health RN, MN. Nurse Educator, National Center for Immunization and Respiratory Diseases, Centers for Disease MA, MBA. Health Communications Specialist Contractor. National Center for Immunization and Respiratory MD, MPH. Senior Director, Performance Measurement, National Quality Forum BSN. Nurse Educator, National Center for Immunization and Respiratory Diseases, Centers for Disease MD, MSC. Assistant Commissioner, New York City Department of Health and Mental Hygiene 4

5 OBJECTIVES Describe emerging challenges in the field of immunization. List at least two things that must be considered in determining a patient s need for immunization. ACCREDITATION STATEMENTS: CME: The Centers for Disease is accredited by the Accreditation Council for Continuing Medical Education (ACCME ) to provide continuing medical education for physicians. The Centers for Disease designates this live event for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CNE: The Centers for Disease is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 14.2 contact hours. CEU: The Centers for Disease is authorized by IACET to offer 1.2 CEU's for this program. CECH: Sponsored by the Centers for Disease, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 17.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number GA0082. DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use. Some of the presenters who are speaking at the National Immunization Conference indicated on their disclosure forms that they have a potential conflict of interest. These presenters and their disclosures follow: CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of those persons listed in Section A. Planning committee discussed conflict of interest with presenters to ensure that is no bias. 5

6 A. Financial Interest or Relationship with Commercial Supporter Givner, Laurence B. Rothholz, Mitchel C. Swanson, Wendy Sue Talbot, H. Keipp Wake Forest School of Medicine American Pharmacists Association Seattle Children s hospital Vanderbilt University Medical Center Has received research support as a member of a multicenter study group from Pfizer. Conflict resolved by discussion with presenter to ensure there is no bias. Spouse receives a salary for employment with Merck. Conflict resolved by discussion with presenter to ensure there is no bias. Has received stock options from Doximity for her role as advisor. Conflict resolved by discussion with presenter to ensure there is no bias. Has received research funds to serve as an investigator from Sanofi Pasteur and MedImmune. Conflict resolved by discussion with presenter to ensure there is no bias. Presentations will not include any discussion of the unlabeled use of a product under investigational use with the exception of those presentations from the speakers listed in Section B. B. Unlabeled Use of Commercial Product or Product for Investigational Use Albert, Alison Centers for Disease Will discuss use of an unlicensed meningococcal vaccine was used in response to outbreaks on 2 college campuses. Breakwell, Lucy Centers for Disease Will discuss the use of an investigational meningococcal B vaccine to control an outbreak at UCSB. Karron, Ruth Johns Hopkins University Will discuss the use of inactivated influenza vaccine in pregnant women. Liang, Jennifer Centers for Disease Will discuss/recommend Tdap vaccination for women during every pregnancy. Markowitz, Lauri Centers for Disease Will discuss the 9-valent vaccine that is under review at FDA. McNamara, Lucy Centers for Disease Will discuss guidance for use of a currently unlicensed (investigational) serogroup B meningococcal vaccine. Omer, Saad Emory University, Rollins School of Public Health Will discuss maternal immunization recommendations, which while recommended by ACIP are technically an offlabel use of vaccine. Pilishvili, Tamara Skoff, Tami Centers for Disease Centers for Disease CDC does not accept commercial support. To receive continuing education (CE): Complete the activity. Complete the Evaluation at FEES: There are no fees for CE. Will discuss ACIP-recommended use of pneumococcal conjugate vaccine among adults 19 years or older with immunocompromising conditions. Will discuss ACIP-recommended off-label use of Tdap vaccine. 6